Protective effect of pioglitazone on morphine-induced neuroinflammation in the rat lumbar spinal cord

Journal of Biomedical Science

Volumn 22, Issue 1, 2015, Pages

  Charkhpour, Mohammad ^a   Ghavimi, Hamed ^b   Ghanbarzadeh, Saeed ^a   Yousefi, Bahman ^a,c   Khorrami, Arash ^a   Mesgari, Mehran ^d   Hassanzadeh, Kambiz ^e  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

GW 9662; Morphine; Neuroinflammation; Pioglitazone; PPAR

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MORPHINE; PIOGLITAZONE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CYTOKINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; LUMBAR SPINAL CORD; MALE; MORPHINE TOLERANCE; NERVOUS SYSTEM INFLAMMATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; AGONISTS; ANIMAL; DRUG EFFECTS; DRUG TOLERANCE; IMMUNOLOGY; INFLAMMATION; LUMBAR VERTEBRA; METABOLISM; SPINAL CORD; WISTAR RAT;

ANIMALS; CYTOKINES; DRUG TOLERANCE; INFLAMMATION; LUMBAR VERTEBRAE; MALE; MORPHINE; PPAR GAMMA; RATS; RATS, WISTAR; SPINAL CORD; THIAZOLIDINEDIONES;

EID: 84941992083     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/s12929-015-0187-2     Document Type: Article

References (27)

1. Ghavimi H, Azarfardian A, Maleki-Dizaji N, Hassanzadeh K, Ghanbarzadeh S, Charkhpour M. Acute administration of pioglitazone attenuates morphine withdrawal syndrome in rat: a novel role of pioglitazone. Drug Res. 2014;6:6.
2. Ghavimi H, Hassanzadeh K, Maleki-Dizaji N, Azarfardian A, Ghasami S, Zolali E, et al. Pioglitazone prevents morphine antinociception tolerance and withdrawal symptoms in rats. Naunyn Schmiedebergs Arch Pharmacol. 2014;5:5.
3. Trujillo KA, Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science. 1991;251:85-7.
4. Korn T, Magnus T, Jung S. Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-alpha. Faseb J. 2005;19:1878-80.
5. Hutchinson MR, Coats BD, Lewis SS, Zhang Y, Sprunger DB, Rezvani N, et al. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav Immun. 2008;22:1178-89.
6. Sharifipour M, Izadpanah E, Nikkhoo B, Zare S, Abdolmaleki A, Hassanzadeh K, et al. A new pharmacological role for donepezil: attenuation of morphine-induced tolerance and apoptosis in rat central nervous system. J Biomed Sci. 2014;21:6.
7. Ruzicka BB, Akil H. The interleukin-1beta-mediated regulation of proenkephalin and opioid receptor messenger RNA in primary astrocyte-enriched cultures. Neuroscience. 1997;79:517-24.
8. Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, Zhao TX, et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun. 2010;24:83-95.
9. Watkins LR, Hutchinson MR, Johnston IN, Maier SF. Glia: novel counter-regulators of opioid analgesia. Trends Neurosci. 2005;28:661-9.
10. Shen CH, Tsai RY, Wong CS. Role of neuroinflammation in morphine tolerance: effect of tumor necrosis factor-alpha. Acta Anaesthesiol Taiwan. 2012;50:178-82.
11. Raghavendra V, Tanga FY, DeLeo JA. Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology. 2004;29:327-34.
12. Shen CH, Tsai RY, Shih MS, Lin SL, Tai YH, Chien CC, et al. Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats. Anesth Analg. 2011;112:454-9.
13. Wang Z, Ma W, Chabot JG, Quirion R. Calcitonin gene-related peptide as a regulator of neuronal CaMKII-CREB, microglial p38-NFkappaB and astroglial ERK-Stat1/3 cascades mediating the development of tolerance to morphine-induced analgesia. Pain. 2010;151:194-205.
14. Tai YH, Wang YH, Wang JJ, Tao PL, Tung CS, Wong CS. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats. Pain. 2006;124:77-86.
15. Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol. 2002;2:748-59.
16. Maeshiba Y, Kiyota Y, Yamashita K, Yoshimura Y, Motohashi M, Tanayama S. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys. Arzneimittelforschung. 1997;47:29-35.
17. Ji H, Wang H, Zhang F, Li X, Xiang L, Aiguo S. PPARgamma agonist pioglitazone inhibits microglia inflammation by blocking p38 mitogen-activated protein kinase signaling pathways. Inflamm Res. 2010;59:921-9.
18. Gurley C, Nichols J, Liu S, Phulwani NK, Esen N, Kielian T. Microglia and astrocyte activation by toll-like receptor ligands: modulation by PPAR-gamma agonists. PPAR Res. 2008;453120:453120.
19. Jia HB, Wang XM, Qiu LL, Liu XY, Shen JC, Ji Q, et al. Spinal neuroimmune activation inhibited by repeated administration of pioglitazone in rats after L5 spinal nerve transection. Neurosci Lett. 2013;543:130-5.
20. Le Foll B, Di Ciano P, Panlilio LV, Goldberg SR, Ciccocioppo R. Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence. Curr Drug Targets. 2013;14:768-76.
21. Stopponi S, Somaini L, Cippitelli A, Cannella N, Braconi S, Kallupi M, et al. Activation of nuclear PPARgamma receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seeking. Biol Psychiatry. 2011;69:642-9.
22. Hassanzadeh K, Roshangar L, Habibi-asl B, Farajnia S, Izadpanah E, Nemati M, et al. Riluzole prevents morphine-induced apoptosis in rat cerebral cortex. Pharmacol Rep. 2011;63:697-707.
23. Ghavimi H, Charkhpour M, Ghasemi S, Mesgari M, Hamishehkare H, Hassanzadeh K, et al. Pioglitazone prevents morphine antinociceptive tolerance via ameliorating neuroinflammation in the rat cerebral cortex. Pharmacol Rep. 2014;67:78-84.
24. Kielian T, Drew PD. Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation. J Neurosci Res. 2003;71:315-25.
25. Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci. 2001;24:450-5.
26. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain. 1995;62:259-74.
27. Pancani T, Phelps JT, Searcy JL, Kilgore MW, Chen KC, Porter NM, et al. Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons. J Neurochem. 2009;109:1800-11.